Immunohistochemical characterization of subtypes of male breast carcinoma

Yimin Ge, Nour Sneige, Mahmoud A. Eltorky, Zhiqin Wang, E. Lin, Yun Gong, Ming Guo

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Introduction: Male breast cancer accounts for around 1% of all breast cancer cases but the incidence has risen in recent years. This study aimed to classify the molecular subtypes of male breast cancers based on the expression profile of immunomarkers and to evaluate their association with clinicopathological features and expression patterns of epidermal growth factor receptor (EGFR) and nuclear factor κB (NF-κB).Methods: A total of 42 cases of male breast carcinoma were examined retrospectively using immunostains for estrogen receptor (ER), progesterone receptor (PR), cytokeratin 5/6 (CK5/6), EGFR, and NF-κB. Human epidermal growth factor receptor 2 (HER2) expression was evaluated by immunostaining and confirmed by fluorescent in situ hybridization (FISH).Results: The luminal A subtype was the most common subtype in male breast cancer (83%, 35/42), which was followed by the luminal B subtype (17%, 7/42). Basal-like and HER2+/ER- subtypes were not identified in this group. All carcinomas expressed ER and 67% of them were PR+. High nuclear grades were more common in the luminal B subtype (71%, 5/7) than in the luminal A subtype (34%, 12/35). The luminal B subtype carcinomas expressed EGFR (42%, 3/7) and NF-κB (57%, 4/7) more frequently than the luminal A subtype did (17%, 6/35 and 37%, 13/35, respectively).Conclusions: In our study group, luminal A and B subtypes were the major subtypes of male breast carcinoma. The immunophenotypical features of male breast cancer differ from those of its female counterpart. Luminal B subtype tended to have high nuclear grade and more frequent expression of EGFR and NF-1κB.

Original languageEnglish (US)
Article numberR28
JournalBreast Cancer Research
Volume11
Issue number3
DOIs
StatePublished - May 14 2009

Fingerprint

Male Breast Neoplasms
Epidermal Growth Factor Receptor
Estrogen Receptors
Progesterone Receptors
Keratin-6
Keratin-5
Carcinoma
Fluorescence In Situ Hybridization
Breast Neoplasms
Incidence

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Ge, Y., Sneige, N., Eltorky, M. A., Wang, Z., Lin, E., Gong, Y., & Guo, M. (2009). Immunohistochemical characterization of subtypes of male breast carcinoma. Breast Cancer Research, 11(3), [R28]. https://doi.org/10.1186/bcr2258

Immunohistochemical characterization of subtypes of male breast carcinoma. / Ge, Yimin; Sneige, Nour; Eltorky, Mahmoud A.; Wang, Zhiqin; Lin, E.; Gong, Yun; Guo, Ming.

In: Breast Cancer Research, Vol. 11, No. 3, R28, 14.05.2009.

Research output: Contribution to journalArticle

Ge, Y, Sneige, N, Eltorky, MA, Wang, Z, Lin, E, Gong, Y & Guo, M 2009, 'Immunohistochemical characterization of subtypes of male breast carcinoma', Breast Cancer Research, vol. 11, no. 3, R28. https://doi.org/10.1186/bcr2258
Ge Y, Sneige N, Eltorky MA, Wang Z, Lin E, Gong Y et al. Immunohistochemical characterization of subtypes of male breast carcinoma. Breast Cancer Research. 2009 May 14;11(3). R28. https://doi.org/10.1186/bcr2258
Ge, Yimin ; Sneige, Nour ; Eltorky, Mahmoud A. ; Wang, Zhiqin ; Lin, E. ; Gong, Yun ; Guo, Ming. / Immunohistochemical characterization of subtypes of male breast carcinoma. In: Breast Cancer Research. 2009 ; Vol. 11, No. 3.
@article{e8a40aec35694992ac1dbb56175d5c8b,
title = "Immunohistochemical characterization of subtypes of male breast carcinoma",
abstract = "Introduction: Male breast cancer accounts for around 1{\%} of all breast cancer cases but the incidence has risen in recent years. This study aimed to classify the molecular subtypes of male breast cancers based on the expression profile of immunomarkers and to evaluate their association with clinicopathological features and expression patterns of epidermal growth factor receptor (EGFR) and nuclear factor κB (NF-κB).Methods: A total of 42 cases of male breast carcinoma were examined retrospectively using immunostains for estrogen receptor (ER), progesterone receptor (PR), cytokeratin 5/6 (CK5/6), EGFR, and NF-κB. Human epidermal growth factor receptor 2 (HER2) expression was evaluated by immunostaining and confirmed by fluorescent in situ hybridization (FISH).Results: The luminal A subtype was the most common subtype in male breast cancer (83{\%}, 35/42), which was followed by the luminal B subtype (17{\%}, 7/42). Basal-like and HER2+/ER- subtypes were not identified in this group. All carcinomas expressed ER and 67{\%} of them were PR+. High nuclear grades were more common in the luminal B subtype (71{\%}, 5/7) than in the luminal A subtype (34{\%}, 12/35). The luminal B subtype carcinomas expressed EGFR (42{\%}, 3/7) and NF-κB (57{\%}, 4/7) more frequently than the luminal A subtype did (17{\%}, 6/35 and 37{\%}, 13/35, respectively).Conclusions: In our study group, luminal A and B subtypes were the major subtypes of male breast carcinoma. The immunophenotypical features of male breast cancer differ from those of its female counterpart. Luminal B subtype tended to have high nuclear grade and more frequent expression of EGFR and NF-1κB.",
author = "Yimin Ge and Nour Sneige and Eltorky, {Mahmoud A.} and Zhiqin Wang and E. Lin and Yun Gong and Ming Guo",
year = "2009",
month = "5",
day = "14",
doi = "10.1186/bcr2258",
language = "English (US)",
volume = "11",
journal = "Breast Cancer Research",
issn = "1465-5411",
publisher = "BioMed Central",
number = "3",

}

TY - JOUR

T1 - Immunohistochemical characterization of subtypes of male breast carcinoma

AU - Ge, Yimin

AU - Sneige, Nour

AU - Eltorky, Mahmoud A.

AU - Wang, Zhiqin

AU - Lin, E.

AU - Gong, Yun

AU - Guo, Ming

PY - 2009/5/14

Y1 - 2009/5/14

N2 - Introduction: Male breast cancer accounts for around 1% of all breast cancer cases but the incidence has risen in recent years. This study aimed to classify the molecular subtypes of male breast cancers based on the expression profile of immunomarkers and to evaluate their association with clinicopathological features and expression patterns of epidermal growth factor receptor (EGFR) and nuclear factor κB (NF-κB).Methods: A total of 42 cases of male breast carcinoma were examined retrospectively using immunostains for estrogen receptor (ER), progesterone receptor (PR), cytokeratin 5/6 (CK5/6), EGFR, and NF-κB. Human epidermal growth factor receptor 2 (HER2) expression was evaluated by immunostaining and confirmed by fluorescent in situ hybridization (FISH).Results: The luminal A subtype was the most common subtype in male breast cancer (83%, 35/42), which was followed by the luminal B subtype (17%, 7/42). Basal-like and HER2+/ER- subtypes were not identified in this group. All carcinomas expressed ER and 67% of them were PR+. High nuclear grades were more common in the luminal B subtype (71%, 5/7) than in the luminal A subtype (34%, 12/35). The luminal B subtype carcinomas expressed EGFR (42%, 3/7) and NF-κB (57%, 4/7) more frequently than the luminal A subtype did (17%, 6/35 and 37%, 13/35, respectively).Conclusions: In our study group, luminal A and B subtypes were the major subtypes of male breast carcinoma. The immunophenotypical features of male breast cancer differ from those of its female counterpart. Luminal B subtype tended to have high nuclear grade and more frequent expression of EGFR and NF-1κB.

AB - Introduction: Male breast cancer accounts for around 1% of all breast cancer cases but the incidence has risen in recent years. This study aimed to classify the molecular subtypes of male breast cancers based on the expression profile of immunomarkers and to evaluate their association with clinicopathological features and expression patterns of epidermal growth factor receptor (EGFR) and nuclear factor κB (NF-κB).Methods: A total of 42 cases of male breast carcinoma were examined retrospectively using immunostains for estrogen receptor (ER), progesterone receptor (PR), cytokeratin 5/6 (CK5/6), EGFR, and NF-κB. Human epidermal growth factor receptor 2 (HER2) expression was evaluated by immunostaining and confirmed by fluorescent in situ hybridization (FISH).Results: The luminal A subtype was the most common subtype in male breast cancer (83%, 35/42), which was followed by the luminal B subtype (17%, 7/42). Basal-like and HER2+/ER- subtypes were not identified in this group. All carcinomas expressed ER and 67% of them were PR+. High nuclear grades were more common in the luminal B subtype (71%, 5/7) than in the luminal A subtype (34%, 12/35). The luminal B subtype carcinomas expressed EGFR (42%, 3/7) and NF-κB (57%, 4/7) more frequently than the luminal A subtype did (17%, 6/35 and 37%, 13/35, respectively).Conclusions: In our study group, luminal A and B subtypes were the major subtypes of male breast carcinoma. The immunophenotypical features of male breast cancer differ from those of its female counterpart. Luminal B subtype tended to have high nuclear grade and more frequent expression of EGFR and NF-1κB.

UR - http://www.scopus.com/inward/record.url?scp=74049140876&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=74049140876&partnerID=8YFLogxK

U2 - 10.1186/bcr2258

DO - 10.1186/bcr2258

M3 - Article

C2 - 19442295

AN - SCOPUS:74049140876

VL - 11

JO - Breast Cancer Research

JF - Breast Cancer Research

SN - 1465-5411

IS - 3

M1 - R28

ER -